Rising rates of macrolide-resistant mycoplasma pneumoniae in the central united states

Pediatric Infectious Disease Journal

Volumn 31, Issue 4, 2012, Pages 409-411

  Yamada, Masaki ^a   Buller, Richard ^a   Bledsoe, Stephanie ^b   Storch, Gregory A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

23rRNA; Macrolide resistance; Mycoplasma pneumoniae; real time PCR

Indexed keywords

BACTERIAL DNA; MACROLIDE; RNA 23S;

ANTIBIOTIC RESISTANCE; ARTICLE; CENTRAL AMERICA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; INFECTION RATE; LUNG LAVAGE; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; THROAT CULTURE; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; DRUG RESISTANCE, BACTERIAL; HUMANS; MACROLIDES; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; PREVALENCE; UNITED STATES;

EID: 84858796185     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318247f3e0     Document Type: Article

References (12)

1. Block S, Hedrick J, Hammerschlag MR, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J. 1995;14:471-477.
2. Liu Y, Ye X, Zhang H, et al. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China. Diagn Microbiol Infect Dis. 2010;67:355-358.
3. Morozumi M, Takahashi T, Ubukata K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother. 2010;16:78-86.
4. Chironna M, Sallustio A, Esposito S, et al. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J Antimicrob Chemother. 2011;66:734-737.
5. Pereyre S, Charron A, Renaudin H, et al. First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J Clin Microbiol. 2007;45:3534-3539. (Pubitemid 350156844)
6. Wolff BJ, Thacker WL, Schwartz SB, et al. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother. 2008;52:3542-3549.
7. Li X, Atkinson TP, Hagood J, et al. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates. Pediatr Infect Dis J. 2009;28:693-696.
8. Jensen JS, Bradshaw CS, Tabrizi SN, et al. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis. 2008;47:1546-1553.
9. Matsubara K, Morozumi M, Okada T, et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J Infect Chemother. 2009;15:380-383.
10. Cao B, Zhao CJ, Yin YD, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis. 2010;51:189-194.
11. Lu A, Wang L, Zhang X, et al. Combined treatment for refractory Mycoplasma pneumoniae Pneumonia with Ciprofloxacin and Glucocorticoid. Pediatr Pulmonol 2011;46:1093-1097.
12. Lung DC, Chan YH, Kwong L, et al. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy. Hong Kong Med J. 2011;17:407-409.